Di-n-butyl ether | CAS:142-96-1
Di-n-butyl ether
- Name：Di-n-butyl ether
- CAS：142-96-1
- Synonyms：n-Butyl ether
- Molecular Formula：C8H18O
- Molecular Weight：130.23
- EINESC：205-575-3
Description
Properties
| Melting point | -95 ºC |
|---|---|
| Water Solubility | 0.03 g/100 mL (20 ºC) |
| Boiling point | 141 ºC |
| Flash point | 25 ºC |
| Density | 0.768 |
| Refractive index | 1.3978-1.3998 |
Safety
| Symbol(GHS) | Xi |
|---|---|
| Hazard Codes | R10;R36/37/38;R52/53 |
| SDS/MSDS | S61 |
SDS
| Source | SDS/MSDS Samples |
|---|---|
| 没有数据 | 没有数据 |
Synthetic Route
| Name | CAS |
|---|
More
Articles
Peer-Reviewed Papers
[Synthesis and alpha-adrenolytic activities of 2-(1,4-benzodioxan-2-yl- methyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives].E Glusa et al.Die Pharmazie, 45(6), 408-410 (1990-06-01)
Cactus alkaloids XLII: 3,4-dimethoxy-beta-phenethylamine and heliamine from the Mexican cereoid Backebergia militaris.R Mata et al.Journal of pharmaceutical sciences, 69(1), 94-95 (1980-01-01)
The effect of an isoquinoline analogue on voluntary ethanol ingestion in rats.S Naeger et al.Proceedings of the Western Pharmacology Society, 34, 35-37 (1991-01-01)
Heterocycles, 34, 1857-1857 (1992)
Gas chromatographic/mass spectrometric evidence for the identification of 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline as a normal constituent of rat brain. Its quantification and comparison to rat whole brain levels of dopamine.S A Barker et al.Biochemical pharmacology, 30(17), 2461-2468 (1981-09-01)
Relationship between exposure of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a "funny" if current channel inhibitor, and heart rate reduction in tachycardia-induced beagle dogs.Ken-ichi Umehara et al.Drug metabolism and disposition: the biological fate of chemicals, 37(7), 1427-1433 (2009-04-11)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
| Name | CAS |
|---|
Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!